Sibutramine Pregnancy and Breastfeeding Warnings
Sibutramine is also known as: Meridia
Sibutramine Pregnancy Warnings
The tissues into which sibutramine usually gets distributed (primarily the liver and kidney) have been unaffected by pregnancy. Relatively low transfer to the fetus has been reported.
Sibutramine has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of maternal toxicity, cardiovascular anomalies, broad short snout, short rounded pinnae, short tail, and shorter thickened long bones in the limbs. There are no adequate controlled data in human pregnancy. The use of sibutramine is considered contraindicated during pregnancy. It is recommended that women of child bearing potential use adequate contraception while on sibutramine therapy. Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy.
Sibutramine Breastfeeding Warnings
There are no data on the excretion of sibutramine into human milk. Sibutramine is considered contraindicated during breast-feeding by the manufacturer. Patients should be advised to notify their physician if they are breast-feeding.
- Sibutramine use while Breastfeeding (in more detail)
- sibutramine Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.